Story perspectives
Breakthrough Nanoparticle Vaccine Achieves 80% Cancer Survival in Mice
10/10/2025
49 9
1 of 1
Story summary
- The nanoparticle vaccine prevented multiple cancers in mice, with 80% survival over 250 days.
- It targets melanoma, pancreatic, and triple-negative breast cancer using a two-adjuvant 'super-adjuvant' system.
- Vaccinated mice showed long-term immunity and successfully resisted new cancer cells after exposure.
- Safety showed no significant toxicity; only transient weight loss observed.
